Osaic Holdings
IMRX icon

Osaic Holdings’s Immuneering IMRX Stock Holding History

Osaic Holdings’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$74 Hold
18
– – ﹤0.01% 7937
2026
Q2 		$90 Buy
18
+14
+350% +$71 ﹤0.01% 7843
2026
Q1 		$21 Sell
4
-4,296
-100% -$22K ﹤0.01% 7720
2025
Q4 		$28.3K Hold
4,300
– – ﹤0.01% 5624
2025
Q3 		$30.1K Hold
4,300
– – ﹤0.01% 5652
2025
Q2 		$14.5K Buy
+4,300
New +$7.37K ﹤0.01% 5936
2024
Q2 		– Sell
-1,000
Closed -$2.89K – 7511
2024
Q1 		$2.89K Buy
+1,000
New +$5.6K ﹤0.01% 6322

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Levin Capital Strategies
Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return

Osaic Holdings's IMRX Position: Q3 2026 in Review

Osaic Holdings held its Immuneering (IMRX) position steady in Q3 2026 at 18 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #7937.

Osaic Holdings first reported a position in IMRX in Q1 2024 and has held it in 7 quarters since. The position peaked at $30.1K in Q3 2025. 65 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

  • Osaic Holdings held 18 shares of Immuneering worth $74 as of Q3 2026.
  • Osaic Holdings left its Immuneering share count unchanged in Q3 2026.
  • Immuneering made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7937 holding.
  • Osaic Holdings first reported a position in Immuneering in Q1 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Immuneering position peaked at $30.1K in Q3 2025.
  • 65 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.